Novo Nordisk unveils plan to expand cardiovascular disease treatment pipeline
Go back to Novo Nordisk unveils plan to expand cardiovascular disease treatment pipeline| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 46.12 +2.93 (6.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.19 | 52 Week High | $59.00 | |||
| Open | $44.01 | 52 Week Low | $32.80 | |||
| Day High | $46.25 | P/E | N/A | |||
| Day Low | $43.90 | EPS | $0.00 | |||
| Volume | 9,382,632 | |||||
